Julie Andrews

CIK: 0001550508

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

RXST

RxSight, Inc.

Director

OFIX

Orthofix Medical Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

RXST
RxSight, Inc.
Jun 17, 2026
Award(A)
Direct
37K shares-
OFIX
Orthofix Medical Inc.
Mar 5, 2026
Sale(S)
Direct
2.4K shares at avg. $12.55$30K
OFIX
Orthofix Medical Inc.
Mar 4, 2026
Sale(S)
Direct
2.4K shares at avg. $12.92$31K
OFIX
Orthofix Medical Inc.
Mar 3, 2026
Award(A)
Direct
35.5K shares-
OFIX
Orthofix Medical Inc.
Jan 16, 2026
Sale(S)
Direct
4.9K shares at avg. $14.38$70K
RXST
RxSight, Inc.
Jun 3, 2025
Award(A)
Direct
10.8K shares-
OFIX
Orthofix Medical Inc.
Mar 3, 2025
Award(A)
Direct
34.6K shares-
OFIX
Orthofix Medical Inc.
Jan 16, 2025
Sale(S)
Direct
4.7K shares at avg. $17.89$83K

		Type	Shares	Price		Ownership
Jun 17, 2026	RXST RxSight, Inc.	Award(A)	37,037	-	$0	Direct
Mar 5, 2026	OFIX Orthofix Medical Inc.	Sale(S)	2,363	$12.55	$29,658	Direct
Mar 4, 2026	OFIX Orthofix Medical Inc.	Sale(S)	2,425	$12.92	$31,322	Direct
Mar 3, 2026	OFIX Orthofix Medical Inc.	Award(A)	35,495	-	$0	Direct
Jan 16, 2026	OFIX Orthofix Medical Inc.	Sale(S)	4,873	$14.38	$70,074	Direct
Jun 3, 2025	RXST RxSight, Inc.	Award(A)	10,752	-	-	Direct
Mar 3, 2025	OFIX Orthofix Medical Inc.	Award(A)	34,600	-	-	Direct
Jan 16, 2025	OFIX Orthofix Medical Inc.	Sale(S)	4,655	$17.89	$83,278	Direct

1-8 of 8 transactions

About Andrews Julie

Andrews Julie (SEC CIK 0001550508) files insider reports with the SEC as Director of RxSight, Inc. (RXST) and CFO of Orthofix Medical Inc. (OFIX).

Signal8 holds 7 ownership filings by Andrews Julie, all Form 4s, filed between Jan 21, 2025 and Jun 18, 2026. Those filings report 8 transactions, from Jan 16, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Andrews Julie's filings is in ALISO VIEJO, CA.

Recent filings by Andrews Julie

Jun 17, 2026: Grant or award of RXST shares (Form 4, code A).
Mar 5, 2026: Open-market sale of OFIX shares (Form 4, code S).
Mar 4, 2026: Open-market sale of OFIX shares (Form 4, code S).
Mar 3, 2026: Grant or award of OFIX shares (Form 4, code A).
Jan 16, 2026: Open-market sale of OFIX shares (Form 4, code S).

Other insiders filing for RxSight, Inc. (RXST)

Weinberg Eric
Wilterding Mark, Chief Financial Officer
Kurtz Ronald M MD, Chief Medical Officer
Goldshleger Ilya, Chief Operating Officer
Mottiwala Aziz, President and CEO
Warner Robert Keith, Director

How to read Form 4 transaction codes